Sector consensus Boston Scientific Corporation

Equities

Market Closed - Nyse Other stock markets 21:00:02 05/12/2025 GMT			5-day change	1st Jan Change
97.52 ^USD	-0.20%		-4.00%	+9.18%

12-02	Boston Scientific Insider Sold Shares Worth $1,758,189, According to a Recent SEC Filing	MT
12-02	Aclarion, Inc. Appoints Jason Brosniak as Commercial Director for the Eastern U.S	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Objective/dr gap	Nbr of analysts
BOSTON SCIENTIFIC CORPORATION	US$126.48	+29.43%	32
THERMO FISHER SCIENTIFIC, INC.	US$619.96	+7.77%	21
INTUITIVE SURGICAL, INC.	US$596.36	+4.88%	29
DANAHER CORPORATION	US$255.67	+12.56%	21
SIEMENS HEALTHINEERS AG	€57.09	+33.87%	19
EDWARDS LIFESCIENCES CORPORATION	US$94.19	+9.81%	28
AGILENT TECHNOLOGIES, INC.	US$169.4	+14.21%	15
GE HEALTHCARE TECHNOLOGIES INC.	US$88.11	+6.78%	20
RESMED, INC.	US$293.47	+16.68%	15
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	CN¥280.05	+40.02%	21
PHILIPS NV	€26.99	+18.79%	17
WATERS CORPORATION	US$388.58	-1.96%	14
ILLUMINA, INC.	US$121.39	-5.19%	18
HOLOGIC, INC.	US$76.5	+2.19%	12
OLYMPUS CORPORATION	JP¥2,077.69	+1.55%	13
REVVITY, INC.	US$113.67	+10.84%	15
BRUKER CORPORATION	US$48.83	+0.94%	12
XTALPI HOLDINGS LIMITED	HK$10.12	+10.76%	3
TRANSMEDICS GROUP, INC.	US$143	+3.15%	11
CARL ZEISS MEDITEC AG	€53.66	+23.92%	16
Average	282.06	+12.05%	18
Weighted average by Cap.	358.57	+13.35%	23